相似文献
1
The Impact of Nanomedicine on Soft Tissue Sarcoma Treated by Radiotherapy and/or Hyperthermia: A Review.
Cancers (Basel). 2024 Jan 17;16(2):0. doi: 10.3390/cancers16020393.
2
Current trials and new aspects in soft tissue sarcoma of adults.
Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S4-8. doi: 10.1007/s00280-002-0445-3. Epub 2002 Apr 16.
3
The Feasibility Study of Hypofractionated Radiotherapy with Regional Hyperthermia in Soft Tissue Sarcomas.
Cancers (Basel). 2021 Mar 16;13(6):1332. doi: 10.3390/cancers13061332.
4
Soft tissue sarcoma in children: prognosis and management.
Paediatr Drugs. 2002;4(1):21-8. doi: 10.2165/00128072-200204010-00003.
5
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
Radiat Oncol. 2022 Aug 8;17(1):139. doi: 10.1186/s13014-022-02106-2.
6
The Effect of chemo- and radiotherapy on tumor necrosis in soft tissue sarcoma- does it influence prognosis?
BMC Cancer. 2024 Mar 6;24(1):303. doi: 10.1186/s12885-024-12027-w.
7
Clinical outcomes of radio-hyperthermo-chemotherapy for soft tissue sarcoma compared to a soft tissue sarcoma registry in Japan: a retrospective matched-pair cohort study.
Cancer Med. 2018 Apr;7(4):1560-1571. doi: 10.1002/cam4.1366. Epub 2018 Feb 26.
8
Human mesenchymal stromal cells do not promote recurrence of soft tissue sarcomas in mouse xenografts after radiation and surgery.
Cytotherapy. 2018 Aug;20(8):1001-1012. doi: 10.1016/j.jcyt.2018.05.011. Epub 2018 Jul 31.
9
Hyperthermia as an adjunctive treatment for soft-tissue sarcoma.
Expert Rev Anticancer Ther. 2009 Feb;9(2):199-210. doi: 10.1586/14737140.9.2.199.
10
Advances in Radiation Therapy for Primary and Metastatic Adult Soft Tissue Sarcomas.
Curr Oncol Rep. 2016 Jun;18(6):36. doi: 10.1007/s11912-016-0523-z.
引用本文的文献
1
Recent Progress of Nanomedicine for the Synergetic Treatment of Radiotherapy (RT) and Photothermal Treatment (PTT).
Cancers (Basel). 2025 Jul 10;17(14):2295. doi: 10.3390/cancers17142295.
本文引用的文献
1
Conjugated Nanoparticles for Solid Tumor Theranostics: Unraveling the Interplay of Known and Unknown Factors.
ACS Omega. 2023 Oct 5;8(41):37654-37684. doi: 10.1021/acsomega.3c05069. eCollection 2023 Oct 17.
2
Combination of Genomic Landsscape and 3D Culture Functional Assays Bridges Sarcoma Phenotype to Target and Immunotherapy.
Cells. 2023 Sep 4;12(17):2204. doi: 10.3390/cells12172204.
3
Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems.
Nanomaterials (Basel). 2023 Jul 31;13(15):2225. doi: 10.3390/nano13152225.
4
Companion Animals as a Key to Success for Translating Radiation Therapy Research into the Clinic.
Cancers (Basel). 2023 Jun 27;15(13):3377. doi: 10.3390/cancers15133377.
5
Phase I study of cisplatin and nanoparticle albumin-bound-paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma.
Cancer Med. 2023 Jul;12(14):15187-15198. doi: 10.1002/cam4.6205. Epub 2023 Jun 19.
6
Brachytherapy in the Treatment of Soft-Tissue Sarcomas of the Extremities-A Current Concept and Systematic Review of the Literature.
Cancers (Basel). 2023 Feb 10;15(4):1133. doi: 10.3390/cancers15041133.
7
Nanoparticles for cancer therapy: a review of influencing factors and evaluation methods for biosafety.
Clin Transl Oncol. 2023 Jul;25(7):2043-2055. doi: 10.1007/s12094-023-03117-5. Epub 2023 Feb 19.
8
Publishing Translational Research of Nanomedicine in .
ACS Nano. 2022 Nov 22;16(11):17479-17481. doi: 10.1021/acsnano.2c10967.
9
Development of Core@Shell γ-FeO@MnO@SiO Nanoparticles for Hyperthermia, Targeting, and Imaging Applications.
ACS Appl Bio Mater. 2022 Nov 21;5(11):5386-5393. doi: 10.1021/acsabm.2c00758. Epub 2022 Nov 9.
10
Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trials.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1867. doi: 10.1002/wnan.1867. Epub 2022 Oct 28.
Zotero 插件